BB&T Corp purchased a new stake in Cantel Medical Corp. (NYSE:CMD) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 4,761 shares of the company’s stock, valued at approximately $371,000.
Several other institutional investors have also modified their holdings of the company. Integrated Investment Consultants LLC acquired a new position in shares of Cantel Medical Corp. during the second quarter valued at $161,000. LS Investment Advisors LLC acquired a new position in shares of Cantel Medical Corp. during the second quarter valued at $172,000. First Quadrant L P CA acquired a new position in shares of Cantel Medical Corp. during the second quarter valued at $233,000. Bank of Montreal Can acquired a new position in shares of Cantel Medical Corp. during the second quarter valued at $248,000. Finally, US Bancorp DE acquired a new position in shares of Cantel Medical Corp. during the second quarter valued at $249,000. 83.66% of the stock is owned by institutional investors.
Cantel Medical Corp. (NYSE CMD) opened at 75.16 on Friday. Cantel Medical Corp. has a 1-year low of $68.19 and a 1-year high of $88.81. The firm has a market capitalization of $3.12 billion, a price-to-earnings ratio of 44.47 and a beta of 1.23. The company has a 50 day moving average price of $75.63 and a 200-day moving average price of $76.80.
Cantel Medical Corp. (NYSE:CMD) last issued its quarterly earnings data on Thursday, June 8th. The company reported $0.51 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.51. The firm had revenue of $192.10 million for the quarter, compared to analyst estimates of $193.84 million. Cantel Medical Corp. had a return on equity of 17.75% and a net margin of 9.50%. Cantel Medical Corp.’s quarterly revenue was up 10.6% on a year-over-year basis. On average, analysts forecast that Cantel Medical Corp. will post $2.06 EPS for the current fiscal year.
The firm also recently disclosed a semiannual dividend, which was paid on Monday, July 31st. Stockholders of record on Monday, July 17th were given a $0.07 dividend. The ex-dividend date of this dividend was Thursday, July 13th. This represents a dividend yield of 0.18%. Cantel Medical Corp.’s dividend payout ratio is currently 8.28%.
COPYRIGHT VIOLATION WARNING: This piece was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.com-unik.info/2017/08/19/bbt-corp-invests-371000-in-cantel-medical-corp-nysecmd-updated-updated.html.
Several brokerages have recently weighed in on CMD. Sidoti raised shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price target for the company in a research note on Wednesday, August 2nd. Zacks Investment Research raised Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a report on Tuesday, August 1st. Benchmark Co. downgraded Cantel Medical Corp. from a “buy” rating to a “hold” rating in a report on Friday, June 9th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical Corp. in a report on Thursday, June 8th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Cantel Medical Corp. has an average rating of “Hold” and a consensus target price of $91.67.
In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 35,000 shares of Cantel Medical Corp. stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total transaction of $2,643,200.00. Following the completion of the transaction, the chairman now owns 3,114,520 shares in the company, valued at $235,208,550.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Charles M. Diker sold 13,000 shares of Cantel Medical Corp. stock in a transaction on Monday, June 12th. The shares were sold at an average price of $76.36, for a total value of $992,680.00. Following the transaction, the chairman now owns 3,124,222 shares of the company’s stock, valued at approximately $238,565,591.92. The disclosure for this sale can be found here. 14.90% of the stock is currently owned by company insiders.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
What are top analysts saying about Cantel Medical Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cantel Medical Corp. and related companies.